Update on Fiasp insulin 17 August 2023 Diabetes Australia have been consistently talking with both the Federal Government and Novo Nordisk about the need for a solution before 1 October 2023. We have been advised that negotiations are continuing. Both the Government and the manufacturer have been made aware of the significant angst this is causing the diabetes community Diabetes Australia will continue to advocate on this issue. We have set up a page – Fight for Fiasp – where you can lend your voice and advocate on this issue. We will keep you updated, as and when we hear anything on this issue.
Media releases 22 November 2023 Regional and remote Australians urged to get late flu vaccine People living with diabetes in rural and remote areas are being urged to get their flu shot now after low rates of flu vaccinations have put communities at risk across Australia this year. Continue Reading
News 10 November 2023 ‘Green lane’ for people with diabetes to navigate airport security Some Australians living with diabetes are experiencing distress getting through airport security screening, so Diabetes Australia is taking action to educate workers and improve the experience for people living with diabetes. Continue Reading
Blog 22 September 2023 Q&A on Fiasp Penfill listing on the PBS On 18 September, Minister for Health and Aged Care, Hon Mark Butler MP, announced that Fiasp insulin will continue to... Continue Reading
